Search clinical trials for: Saxenda®

Total 13813 results

Woman's
Novo Nordisk A/S

Completed

Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOS (SAXAPCOS)

Polycystic Ovary Syndrome | Pre Diabetes | Obesity Android

United States
Amgen

Completed

Multiple Ascending Dose Study of AMG 598 in Adults With Obesity

Obesity

United States
Novo Nordisk A/S

Completed

A Research Study About Weight Loss and Treatment Patterns With the Use of Saxenda® in Adults in Real-life Settings in Switzerland

Obesity or Overweight

Denmark
University College, London

Completed

Evaluation of Liraglutide 3.0mg in Patients With Poor Weight-loss and a Suboptimal Glucagon-like Peptide-1 Response (BARIOPTIMISE)

Obesity

United Kingdom
Federico II University

Unknown

Effect of Liraglutide on Microbiome in Obesity

Obesity | Weight Loss | Microbiome

Italy
Novo Nordisk A/S

Enrolling by invitation

Study to Evaluate the Safety and Effectiveness of Saxenda® for Weight Management in Routine Clinical Practice in Taiwan.

Obesity

Taiwan
Anders Fink-Jensen, MD, DMSci

Completed

Is Saxenda® a Viable Treatment of Obese Patients in Forensic Psychiatry?

Feasibility | Overweight and Obesity | Metabolic Disturbance | Mental Disorder | Liraglutide

Denmark
Mayo Clinic
Novo Nordisk A/S

Active, not recruiting

Effect of GLP-1 Receptor Agonism After Sleeve Gastrectomy

Obesity

United States
Merck Sharp & Dohme LLC

Completed

Pharmacokinetics of MK-3682B in Participants With Moderate to Severe Renal Insufficiency (MK-3682B-030)

Hepatitis C
Texas Tech University
Novo Nordisk A/S

Completed

To Predict Weight Loss Response to Liraglutide (Saxenda®), From fMRI-based Determination of Food Cue Reactivity

Obesity

United States
University of Chicago

Not yet recruiting

Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues

Multiple Sclerosis | Obesity | Obesity, Morbid | Obese | Long COVID | Long Covid19 | Acute Leukemia in Remission
Boehringer Ingelheim

Completed

A Study in Men With Overweight to Test How Well Different Doses of BI 1820237 Are Tolerated When Given as an Injection Alone or in Combination With Liraglutide

Healthy

Germany
Cambridge University Hospitals NHS Foundation Trust

Completed

Patient Agenda Setting and Clinic Efficiency in Outpatients

Respiratory Tract Diseases

United Kingdom
Washington University School of Medicine
Northwestern University

Completed

Corticolimbic Degeneration and Treatment of Dementia

Dementia
Claus Bogh Juhl

Completed

Effects of Liraglutide in Chronic Obstructive Pulmonary Disease

Pulmonary Disease, Chronic Obstructive

Denmark
Chinese PLA General Hospital

Unknown

Clinical Study of Liraglutide in Improving Cardiac Function for Patients With Ischemic Cardiomyopathy

Ischemic Cardiomyopathy

China
University of Texas Southwestern Medical Center
Novo Nordisk A/S

Completed

Impact of Liraglutide 3.0 on Body Fat Distribution

Cardiovascular Diseases | Fat Disorder | Obesity, Visceral

United States
University Hospitals Coventry and Warwickshire...
University of Warwick; University of Birmingham; Kingston University

Unknown

3mg Liraglutide for Overweight or Obesity

Obesity | Overweight | Infertility, Female

United Kingdom
King's College London

Completed

Splenda: Effects on Blood Glucose Concentration, Appetite Scores and Subsequent Energy Intake

Glucose Metabolism Disorders | Appetitive Behavior

United Kingdom
Ohio State University

Completed

Improving Beta Cell Function in Mexican American Women With Prediabetes

Pre-Diabetes

United States
Signe Torekov
Karolinska Institutet; University of Oxford; Hvidovre University Hospital

Unknown

Combined Effects of GLP-1 Analogue and Exercise on Maintenance of Weight Loss and Health After Very-low Calorie Diet (S-LITE)

Obesity

Denmark
Mayo Clinic
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Novo...

Completed

Pilot Study of the Effect of Liraglutide on Weight Loss and Gastric Functions in Obesity

Obesity

United States
New York Medical College

Recruiting

CMV CTLs in Neonates With CMV Infection

Congenital Cytomegaloviral (CMV) Disease

United States
Zuyderland Medisch Centrum
Nederlandse Obesitas Kliniek

Withdrawn

Liraglutide for Low-responders After Bariatric Surgery (LIBAR)

Obesity | Obesity, Morbid
General Committee of Teaching Hospitals and Institutes...

Not yet recruiting

Effect of Liraglutide on Weight Loss in Patients Who Have Undergone Revisional Bariatric Surgeries.

Morbid Obesity

Egypt
Beth Israel Deaconess Medical Center

Active, not recruiting

Saxenda: Underlying Mechanisms and Clinical Outcomes

Obesity

United States
Michael Camilleri, MD
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Novo...

Completed

Pilot Study of the Effect of Liraglutide 3.0 mg on Weight Loss and Gastric Functions in Obesity

Obesity

United States
Hospital General de México Dr. Eduardo Liceaga

Completed

Serum Insulin Response After Acute and Chronic Sucralose Ingestion in Healthy Volunteers With Variable Body Mass Index

Healthy
Henrik Gudbergsen

Completed

Biomarkers in Obese Patients With Knee Osteoarthritis; Weight Maintenance (BIO-LOSEIT-II)

Obesity | Osteoarthritis

Denmark
University of Leicester
Novo Nordisk A/S

Active, not recruiting

Saxenda in Obesity Services (STRIVE Study) (STRIVE)

Obesity | Diabetes Mellitus | Weight Loss

Ireland, United Kingdom
NYU Langone Health
Novo Nordisk A/S

Completed

Clinical Efficacy and Safety of Using 3.0mg Liraglutide to Treat Weight Regain After Roux-en-Y Gastric Bypass Surgery

Obesity

United States
Henrik Gudbergsen

Completed

Multi-parametric Imaging of the Knee in Obese Patients With Knee Osteoarthritis; Weight Maintenance (IM-LOSEIT-II)

Obesity | Osteoarthritis

Denmark
Parker Research Institute

Completed

Changes in Skin Autoflouresence Following Weight Loss and Maintenance Using Liraglutide in Knee Osteoarthritis

Osteoarthritis, Knee

Denmark
Rebecca Ashare
Novo Nordisk A/S

Completed

Daily Liraglutide for Nicotine Dependence (DAL)

Smoking Cessation | Weight, Body

United States
Nicolai Jacob Wewer Albrechtsen
Rigshospitalet, Denmark; Hvidovre University Hospital

Completed

The Effect of Liraglutide on Pancreatic Hormones and Its Size (LIRAP)

Obesity

Denmark
Seoul National University Hospital

Recruiting

The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot Study

Craniopharyngioma | Panhypopituitarism | Hypothalamic Obesity

Korea, Republic of
Henrik Gudbergsen
Novo Nordisk A/S; Cambridge Weight Plan Limited

Completed

Liraglutide 3 mg for Knee Osteoarthritis (LOSEIT)

Obesity | Osteoarthritis

Denmark
Henrik Gudbergsen

Completed

Ultrasound of the Knee in Obese Patients With Knee Osteoarthritis; Weight Maintenance (US-LOSEIT-II)

Obesity | Osteoarthritis

Denmark
Massachusetts General Hospital

Recruiting

NTS-WBRT in Brain Metastases

Brain Metastases

United States
Johns Hopkins Bloomberg School of Public Health
Medstar Health Research Institute; Johns Hopkins Community Physicians

Completed

Involving Family to Improve Communication in Primary Care (SAMEPage)

Cognitive Impairment

United States
Forest Laboratories

Completed

Effect of Memantine on Functional Communication in Patients With Alzheimer's Disease

Alzheimer's Disease

Australia, New Zealand, South Africa
Zoltan Pataky
University of Geneva, Switzerland

Completed

Reward Mechanisms in Obesity (LIRAOB)

Obesity

Switzerland
Beni-Suef University

Not yet recruiting

Effect of Liraglutide in Obese Women With Polycystic Ovary Syndrome

Polycystic Ovary

Egypt
Lindner Center of HOPE

Completed

Saxenda® in Obese or Overweight Patients With Stable Bipolar Disorder (Investigator Initiated)

Obesity | Bipolar Disorder

United States
Cedars-Sinai Medical Center
Novo Nordisk A/S; The Cure Parkinson's Trust

Completed

Safety and Efficacy of Liraglutide in Parkinson's Disease

Parkinson Disease

United States
Forest Laboratories
Merz Pharmaceuticals GmbH

Completed

Open-label Study of Safety and Tolerability of Memantine in Children With Autism

Autism | Pediatric Autism

United States
University of Wisconsin, Madison

Completed

A Pilot Trial to Determine the Efficacy of VSL#3 for Reducing Colonization by VRE (PROVE)

Anti-biotic Resistance

United States
Milton S. Hershey Medical Center
National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)

Completed

Use of a GLP-1R Agonist to Treat Opioid Use Disorder

Opioid-Related Disorders | Opiate Substitution Treatment

United States
St Vincent's University Hospital, Ireland
University College Dublin; Health Research Board, Ireland

Completed

Effect of Liraglutide vs CPAP on Cardiometabolic Outcomes in Obstructive Sleep Apnea

Sleep Apnea, Obstructive

Ireland
Dong-A ST Co., Ltd.

Completed

A Study to Demonstrate the Efficacy and Safety of Motilitone®

Functional Dyspepsia

Korea, Republic of

Search clinical trials for: Saxenda®

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations